Al Ain, UAE: Tawam Hospital, in affiliation with Johns Hopkins Medicine and the Seha Healthcare System, is now offering the first lung cancer screening programme in Abu Dhabi and in the UAE.
The programme includes a low-dose computed tomography (LDCT) lung cancer diagnostic screening at its thoracic surgery clinic and aims to improve early detection and reduce the risk of lung cancer mortality, the first time such an initiative has been put in place for the disease.
Within the programme, a patient’s risk factors will be assessed by a physician and the patient may then be asked to undergo a screening using a low-dose CT machine followed by a comprehensive diagnostic evaluation.
Systematic reviews published in the Annals of Internal Medicine concluded that LDCT screening can reduce lung cancer mortality, thereby saving lives, and it is also cost-effective. Well-known international cancer associations and preventive medical task forces have also endorsed the use of LDCT screening.
Most cases of lung cancer reported in Abu Dhabi are male patients over 50 years old. Lung cancer is also the leading cause of cancer death among UAE national men. In fact, 89.2 per cent of Abu Dhabi patients diagnosed with lung cancer found that they had stage three or four cancer at the time of diagnosis, making it more challenging to eliminate the cancerous cells.
“Lung cancer is the most common form of cancer worldwide and is a grave issue for the UAE population. The disease is in dire need of being addressed with a solid plan of action,” said Dr Ali Omar Al Dameh, thoracic surgery consultant. “Our screening facility is the first of its kind in the country to screen specifically for lung cancer. This shows our hospital staff’s determination in preventing, detecting and reducing the likelihood of lung cancer,” he added.
© Gulf News
Twitter